MiRXES collaborates with Plug and Play to launch Southeast Asia's first science-backed commercialization engine and validator program
MiRXES Translator Program will accelerate revenue growth of start-ups and importantly, adoption of preventive healthcare solutions globally SINGAPORE, Oct. 25, 2022 /PRNewswire/ --MiRXES, a Singapore-headquartered biotechnology company focused on saving lives and improving health economics and outcomes through RNA-powered disease early detection and precision genomic tests, today launched the first edition of MiRXES Translator Program, Southeast Asia's first business and clinical advisory program backed by science that bridges post-incubation ideation and post-accelerator growth, at Singap...
Source: philippinetimes.com